首页 > 最新文献

European Journal of Radiology Open最新文献

英文 中文
Peroneus brevis split tear – A challenging diagnosis: A pictorial review of magnetic resonance and ultrasound imaging. Part 1. Anatomical basis and clinical insights
IF 1.8 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-01-08 DOI: 10.1016/j.ejro.2024.100633
Katarzyna Bokwa-Dąbrowska , Rafał Zych , Dan Mocanu , Michael Huuskonen , Dawid Dziedzic , Pawel Szaro
Diagnosing peroneus brevis split tears is a significant challenge, as many cases are missed both clinically and on imaging. Anatomical variations within the superior peroneal tunnel can contribute to peroneus brevis split tears or instability of the peroneal tendons. However, determining which anatomical variations predispose patients to these injuries remains challenging due to conflicting data in the literature. In this review, we present the current understanding of the role of anatomical variants in the development of peroneus brevis split tears. Many studies emphasize the significance of the retromalleolar groove and retromalleolar tubercle, the impact of a low-lying muscle belly, and the presence of accessory muscles within the superior peroneal tunnel as contributors to peroneal pathology. Hypertrophy of the peroneal tubercle or post-traumatic irregularities in the surface of the retromalleolar groove can accelerate degenerative changes in the peroneal tendons, potentially leading to peroneus brevis split tears. The topographic anatomy of the superior peroneal tunnel is essential for systematically performing ultrasound and interpreting magnetic resonance imaging of the ankle. The first part of this review focuses on the anatomical foundations of imaging diagnostics for peroneus brevis pathology. In the second part, we will examine the radiological spectrum of peroneal tendon injuries, offering a framework to enhance diagnostic confidence in this frequently underdiagnosed pathology.
{"title":"Peroneus brevis split tear – A challenging diagnosis: A pictorial review of magnetic resonance and ultrasound imaging. Part 1. Anatomical basis and clinical insights","authors":"Katarzyna Bokwa-Dąbrowska ,&nbsp;Rafał Zych ,&nbsp;Dan Mocanu ,&nbsp;Michael Huuskonen ,&nbsp;Dawid Dziedzic ,&nbsp;Pawel Szaro","doi":"10.1016/j.ejro.2024.100633","DOIUrl":"10.1016/j.ejro.2024.100633","url":null,"abstract":"<div><div>Diagnosing peroneus brevis split tears is a significant challenge, as many cases are missed both clinically and on imaging. Anatomical variations within the superior peroneal tunnel can contribute to peroneus brevis split tears or instability of the peroneal tendons. However, determining which anatomical variations predispose patients to these injuries remains challenging due to conflicting data in the literature. In this review, we present the current understanding of the role of anatomical variants in the development of peroneus brevis split tears. Many studies emphasize the significance of the retromalleolar groove and retromalleolar tubercle, the impact of a low-lying muscle belly, and the presence of accessory muscles within the superior peroneal tunnel as contributors to peroneal pathology. Hypertrophy of the peroneal tubercle or post-traumatic irregularities in the surface of the retromalleolar groove can accelerate degenerative changes in the peroneal tendons, potentially leading to peroneus brevis split tears. The topographic anatomy of the superior peroneal tunnel is essential for systematically performing ultrasound and interpreting magnetic resonance imaging of the ankle. The first part of this review focuses on the anatomical foundations of imaging diagnostics for peroneus brevis pathology. In the second part, we will examine the radiological spectrum of peroneal tendon injuries, offering a framework to enhance diagnostic confidence in this frequently underdiagnosed pathology.</div></div>","PeriodicalId":38076,"journal":{"name":"European Journal of Radiology Open","volume":"14 ","pages":"Article 100633"},"PeriodicalIF":1.8,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11764704/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143048214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CT-based intratumoral and peritumoral radiomics nomogram to predict spread through air spaces in lung adenocarcinoma with diameter ≤ 3 cm: A multicenter study
IF 1.8 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-01-02 DOI: 10.1016/j.ejro.2024.100630
Yangfan Su , Junli Tao , Xiaosong Lan , Changyu Liang , Xuemei Huang , Jiuquan Zhang , Kai Li , Lihua Chen

Purpose

The aim of this study was to explore and develop a preoperative and noninvasive model for predicting spread through air spaces (STAS) status in lung adenocarcinoma (LUAD) with diameter ≤ 3 cm.

Methods

This multicenter retrospective study included 640 LUAD patients. Center I included 525 patients (368 in the training cohort and 157 in the validation cohort); center II included 115 patients (the test cohort). We extracted radiomics features from the intratumor, extended tumor and peritumor regions. Multivariate logistic regression and boruta algorithm were used to select clinical independent risk factors and radiomics features, respectively. We developed a clinical model and four radiomics models (the intratumor model, extended tumor model, peritumor model and fusion model). A nomogram based on prediction probability value of the optimal radiomics model and clinical independent risk factors was developed to predict STAS status.

Results

Maximum diameter and nodule type were clinical independent risk factors. The extended tumor model achieved satisfactory STAS status discrimination performance with the AUC of 0.74, 0.71 and 0.80 in the three cohorts, respectively, performed better than other radiomics models. The integrated discrimination improvement value revealed that the nomogram outperformed compared to the clinical model with the value of 12 %. Patients with high nomogram score (≥ 77.31) will be identified as STAS-positive.

Conclusions

Peritumoral information is significant to predict STAS status. The nomogram based on the extended tumor model and clinical independent risk factors provided good preoperative prediction of STAS status in LUAD with diameter ≤ 3 cm, aiding surgical decision-making.
{"title":"CT-based intratumoral and peritumoral radiomics nomogram to predict spread through air spaces in lung adenocarcinoma with diameter ≤ 3 cm: A multicenter study","authors":"Yangfan Su ,&nbsp;Junli Tao ,&nbsp;Xiaosong Lan ,&nbsp;Changyu Liang ,&nbsp;Xuemei Huang ,&nbsp;Jiuquan Zhang ,&nbsp;Kai Li ,&nbsp;Lihua Chen","doi":"10.1016/j.ejro.2024.100630","DOIUrl":"10.1016/j.ejro.2024.100630","url":null,"abstract":"<div><h3>Purpose</h3><div>The aim of this study was to explore and develop a preoperative and noninvasive model for predicting spread through air spaces (STAS) status in lung adenocarcinoma (LUAD) with diameter ≤ 3 cm.</div></div><div><h3>Methods</h3><div>This multicenter retrospective study included 640 LUAD patients. Center I included 525 patients (368 in the training cohort and 157 in the validation cohort); center II included 115 patients (the test cohort). We extracted radiomics features from the intratumor, extended tumor and peritumor regions. Multivariate logistic regression and boruta algorithm were used to select clinical independent risk factors and radiomics features, respectively. We developed a clinical model and four radiomics models (the intratumor model, extended tumor model, peritumor model and fusion model). A nomogram based on prediction probability value of the optimal radiomics model and clinical independent risk factors was developed to predict STAS status.</div></div><div><h3>Results</h3><div>Maximum diameter and nodule type were clinical independent risk factors. The extended tumor model achieved satisfactory STAS status discrimination performance with the AUC of 0.74, 0.71 and 0.80 in the three cohorts, respectively, performed better than other radiomics models. The integrated discrimination improvement value revealed that the nomogram outperformed compared to the clinical model with the value of 12 %. Patients with high nomogram score (≥ 77.31) will be identified as STAS-positive.</div></div><div><h3>Conclusions</h3><div>Peritumoral information is significant to predict STAS status. The nomogram based on the extended tumor model and clinical independent risk factors provided good preoperative prediction of STAS status in LUAD with diameter ≤ 3 cm, aiding surgical decision-making.</div></div>","PeriodicalId":38076,"journal":{"name":"European Journal of Radiology Open","volume":"14 ","pages":"Article 100630"},"PeriodicalIF":1.8,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11754163/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143029858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential of spectral imaging generated by contrast-enhanced dual-energy CT for lung cancer histopathological classification – A preliminary study 对比增强双能CT光谱成像对肺癌组织病理分类的潜力初步研究。
IF 1.8 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-12-26 DOI: 10.1016/j.ejro.2024.100628
Tomoaki Sasaki , Shioto Oda , Hirofumi Kuno , Takashi Hiyama , Tetsuro Taki , Shugo Takahashi , Genichiro Ishii , Masahiro Tsuboi , Tatsushi Kobayashi

Purpose

The potential of spectral images, particularly electron density and effective Z-images, generated by dual-energy computed tomography (DECT), for the histopathologic classification of lung cancer remains unclear. This study aimed to explore which imaging factors could better reflect the histopathological status of lung cancer.

Method

The data of 31 patients who underwent rapid kV-switching DECT and subsequently underwent surgery for lung cancer were analyzed. Virtual monochromatic images (VMIs) of 35 keV and 70 keV, virtual non-contrast images (VNC), iodine content images, electron density images, and effective Z-images were reconstructed for the following analyses: 1) correlation with the ratio of the lepidic growth pattern in the whole tumor and 2) comparisons with the four histological groups: well-differentiated adenocarcinoma (WDA), moderately differentiated adenocarcinoma (MDA), and poorly differentiated adenocarcinoma (PDA) and squamous cell carcinoma (SCC).

Results

There were significant correlations between the ratio of lepidic growth pattern and 70 keV, 35 keV, VNC, and electron density images (r = -0.861, P < 0.001; r = -0.791, P < 0.001; r = -0.869, P < 0.001; r = -0.871, P < 0.001, respectively). There were significant differences in the 70 keV, 35 keV, VNC, and electron density images in the Kruskal-Wallis test (P = 0.001, P = 0.006, P < 0.001, P < 0.001, respectively). However, there were no significant differences in iodine content or effective Z-images.

Conclusions

Electron density images generated by spectral imaging may be better indicators of the histopathological classification of lung cancer.

Clinical relevance

Electron density images may have an added value in predicting the histopathological classification of lung cancer.

Key points

  • The role of electron density and effective Z-images obtained using dual-energy CT in lung cancer classification remains unclear.
  • Electron density and virtual non-contrast images correlated better with the ratio of lepidic growth patterns in lung cancer.
  • Electron density imaging is a better indicator of the histopathological classification of lung cancer than effective Z-imaging.
目的:由双能计算机断层扫描(DECT)产生的光谱图像,特别是电子密度和有效z图像,在肺癌的组织病理学分类中的潜力尚不清楚。本研究旨在探讨哪些影像学因素能更好地反映肺癌的组织病理状态。方法:对31例肺癌患者行快速电压转换DECT后行手术治疗的资料进行分析。重建35 keV和70 keV的虚拟单色图像(VMIs)、虚拟无对比图像(VNC)、碘含量图像、电子密度图像和有效z -图像,进行以下分析:1)与整个肿瘤中鳞状生长模式比例的相关性,2)与四个组织学组的比较。高分化腺癌(WDA)、中分化腺癌(MDA)、低分化腺癌(PDA)和鳞状细胞癌(SCC)。结果:肺鳞生长模式比值与70 keV、35 keV、VNC、电子密度影像(r = -0.861,P )有显著相关性。结论:光谱成像生成的电子密度影像可能是肺癌组织病理分型的较好指标。临床意义:电子密度图像在预测肺癌的组织病理学分类方面可能有附加价值。•双能CT获得的电子密度和有效z -像在肺癌分类中的作用尚不清楚。•电子密度和虚拟非对比图像与肺癌中鳞状生长模式的比例相关性更好。•电子密度成像比有效的z -显像更能指示肺癌的组织病理分类。
{"title":"Potential of spectral imaging generated by contrast-enhanced dual-energy CT for lung cancer histopathological classification – A preliminary study","authors":"Tomoaki Sasaki ,&nbsp;Shioto Oda ,&nbsp;Hirofumi Kuno ,&nbsp;Takashi Hiyama ,&nbsp;Tetsuro Taki ,&nbsp;Shugo Takahashi ,&nbsp;Genichiro Ishii ,&nbsp;Masahiro Tsuboi ,&nbsp;Tatsushi Kobayashi","doi":"10.1016/j.ejro.2024.100628","DOIUrl":"10.1016/j.ejro.2024.100628","url":null,"abstract":"<div><h3>Purpose</h3><div>The potential of spectral images, particularly electron density and effective Z-images, generated by dual-energy computed tomography (DECT), for the histopathologic classification of lung cancer remains unclear. This study aimed to explore which imaging factors could better reflect the histopathological status of lung cancer.</div></div><div><h3>Method</h3><div>The data of 31 patients who underwent rapid kV-switching DECT and subsequently underwent surgery for lung cancer were analyzed. Virtual monochromatic images (VMIs) of 35 keV and 70 keV, virtual non-contrast images (VNC), iodine content images, electron density images, and effective Z-images were reconstructed for the following analyses: 1) correlation with the ratio of the lepidic growth pattern in the whole tumor and 2) comparisons with the four histological groups: well-differentiated adenocarcinoma (WDA), moderately differentiated adenocarcinoma (MDA), and poorly differentiated adenocarcinoma (PDA) and squamous cell carcinoma (SCC).</div></div><div><h3>Results</h3><div>There were significant correlations between the ratio of lepidic growth pattern and 70 keV, 35 keV, VNC, and electron density images (r = -0.861, P &lt; 0.001; r = -0.791, P &lt; 0.001; r = -0.869, P &lt; 0.001; r = -0.871, P &lt; 0.001, respectively). There were significant differences in the 70 keV, 35 keV, VNC, and electron density images in the Kruskal-Wallis test (P = 0.001, P = 0.006, P &lt; 0.001, P &lt; 0.001, respectively). However, there were no significant differences in iodine content or effective Z-images.</div></div><div><h3>Conclusions</h3><div>Electron density images generated by spectral imaging may be better indicators of the histopathological classification of lung cancer.</div></div><div><h3>Clinical relevance</h3><div>Electron density images may have an added value in predicting the histopathological classification of lung cancer.</div></div><div><h3>Key points</h3><div><ul><li><span>•</span><span><div>The role of electron density and effective Z-images obtained using dual-energy CT in lung cancer classification remains unclear.</div></span></li></ul><ul><li><span>•</span><span><div>Electron density and virtual non-contrast images correlated better with the ratio of lepidic growth patterns in lung cancer.</div></span></li></ul></div><div><ul><li><span>•</span><span><div>Electron density imaging is a better indicator of the histopathological classification of lung cancer than effective Z-imaging.</div></span></li></ul></div></div>","PeriodicalId":38076,"journal":{"name":"European Journal of Radiology Open","volume":"14 ","pages":"Article 100628"},"PeriodicalIF":1.8,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11732575/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142985023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing detection of previously missed non-palpable breast carcinomas through artificial intelligence 通过人工智能增强对先前未发现的非可触及乳腺癌的检测。
IF 1.8 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-12-25 DOI: 10.1016/j.ejro.2024.100629
Sahar Mansour , Rasha Kamal , Samar Ahmed Hussein , Mostafa Emara , Yomna Kassab , Sherif Nasser Taha , Mohammed Mohammed Mohammed Gomaa

Purpose

To investigate the impact of artificial intelligence (AI) reading digital mammograms in increasing the chance of detecting missed breast cancer, by studying the AI- flagged early morphology indictors, overlooked by the radiologist, and correlating them with the missed cancer pathology types.

Methods and materials

Mammograms done in 2020–2023, presenting breast carcinomas (n = 1998), were analyzed in concordance with the prior one year’s result (2019–2022) assumed negative or benign. Present mammograms reviewed for the descriptors: asymmetry, distortion, mass, and microcalcifications. The AI presented abnormalities by overlaying color hue and scoring percentage for the degree of suspicion of malignancy.

Results

Prior mammogram with AI marking compromised 54 % (n = 555), and in the present mammograms, AI targeted 904 (88 %) carcinomas. The descriptor proportion of “asymmetry” was the common presentation of missed breast carcinoma (64.1 %) in the prior mammograms and the highest detection rate for AI was presented by “distortion” (100 %) followed by “grouped microcalcifications” (80 %). AI performance to predict malignancy in previously assigned negative or benign mammograms showed sensitivity of 73.4 %, specificity of 89 %, and accuracy of 78.4 %.

Conclusions

Reading mammograms with AI significantly enhances the detection of early cancerous changes, particularly in dense breast tissues. The AI's detection rate does not correlate with specific pathological types of breast cancer, highlighting its broad utility. Subtle mammographic changes in postmenopausal women, not corroborated by ultrasound but marked by AI, warrant further evaluation by advanced applications of digital mammograms and close interval AI-reading mammogram follow up to minimize the potential for missed breast carcinoma.
目的:通过研究人工智能(AI)标记的早期形态学指标,并将其与漏诊的癌症病理类型进行关联,探讨人工智能(AI)读取数字乳房x线照片对增加漏诊乳腺癌的机会的影响。方法和材料:分析2020-2023年乳房x光片显示的乳腺癌(n = 1998),并与前一年(2019-2022年)的阴性或良性结果一致。目前乳房x光检查的描述:不对称,扭曲,肿块和微钙化。人工智能通过叠加色相和恶性怀疑程度评分百分比来呈现异常。结果:先前有AI标记的乳房x线照片损害了54% % (n = 555),而在目前的乳房x线照片中,AI靶向904(88 %)癌。在之前的乳房x光检查中,“不对称”的描述比例是乳腺癌漏诊的常见表现(64.1 %),AI的最高检出率是“畸变”(100 %),其次是“分组微钙化”(80 %)。人工智能在先前指定的阴性或良性乳房x线照片中预测恶性肿瘤的表现灵敏度为73.4 %,特异性为89 %,准确性为78.4% %。结论:人工智能阅读乳房x线照片可显著提高对早期癌变的发现,特别是在致密乳腺组织中。人工智能的检出率与特定的病理类型无关,突出了其广泛的实用性。绝经后妇女乳房x光检查的细微变化,未被超声证实,但被人工智能标记出来,需要通过先进的数字乳房x光检查和密切间隔的人工智能阅读乳房x光检查随访进一步评估,以尽量减少漏诊乳腺癌的可能性。
{"title":"Enhancing detection of previously missed non-palpable breast carcinomas through artificial intelligence","authors":"Sahar Mansour ,&nbsp;Rasha Kamal ,&nbsp;Samar Ahmed Hussein ,&nbsp;Mostafa Emara ,&nbsp;Yomna Kassab ,&nbsp;Sherif Nasser Taha ,&nbsp;Mohammed Mohammed Mohammed Gomaa","doi":"10.1016/j.ejro.2024.100629","DOIUrl":"10.1016/j.ejro.2024.100629","url":null,"abstract":"<div><h3>Purpose</h3><div>To investigate the impact of artificial intelligence (AI) reading digital mammograms in increasing the chance of detecting missed breast cancer, by studying the AI- flagged early morphology indictors, overlooked by the radiologist, and correlating them with the missed cancer pathology types.</div></div><div><h3>Methods and materials</h3><div>Mammograms done in 2020–2023, presenting breast carcinomas (n = 1998), were analyzed in concordance with the prior one year’s result (2019–2022) assumed negative or benign. Present mammograms reviewed for the descriptors: asymmetry, distortion, mass, and microcalcifications. The AI presented abnormalities by overlaying color hue and scoring percentage for the degree of suspicion of malignancy.</div></div><div><h3>Results</h3><div>Prior mammogram with AI marking compromised 54 % (n = 555), and in the present mammograms, AI targeted 904 (88 %) carcinomas. The descriptor proportion of “asymmetry” was the common presentation of missed breast carcinoma (64.1 %) in the prior mammograms and the highest detection rate for AI was presented by “distortion” (100 %) followed by “grouped microcalcifications” (80 %). AI performance to predict malignancy in previously assigned negative or benign mammograms showed sensitivity of 73.4 %, specificity of 89 %, and accuracy of 78.4 %.</div></div><div><h3>Conclusions</h3><div>Reading mammograms with AI significantly enhances the detection of early cancerous changes, particularly in dense breast tissues. The AI's detection rate does not correlate with specific pathological types of breast cancer, highlighting its broad utility. Subtle mammographic changes in postmenopausal women, not corroborated by ultrasound but marked by AI, warrant further evaluation by advanced applications of digital mammograms and close interval AI-reading mammogram follow up to minimize the potential for missed breast carcinoma.</div></div>","PeriodicalId":38076,"journal":{"name":"European Journal of Radiology Open","volume":"14 ","pages":"Article 100629"},"PeriodicalIF":1.8,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11732583/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142985004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peroneus brevis split tear – A challenging diagnosis: A pictorial review of magnetic resonance and ultrasound imaging – Part 2: Imaging with magnetic resonance and ultrasound 腓骨短肌撕裂-一个具有挑战性的诊断:磁共振和超声成像的图像回顾-第2部分:磁共振和超声成像。
IF 1.8 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-12-22 DOI: 10.1016/j.ejro.2024.100627
Katarzyna Bokwa-Dąbrowska , Dan Mocanu , Isaac Romanus , Rafał Zych , Michael Huuskonen , Pawel Szaro
Peroneal tendon pathology is common among physically active individuals, with tenosynovitis, tendon subluxation, split tears and rupture. However, diagnosing these conditions, particularly peroneus brevis split tears, is clinically and radiologically challenging. Magnetic resonance imaging (MRI) and ultrasound (US) can sometimes miss split tears. A significant portion of peroneus split tears develops on a background of tendinopathy. The presence of tenosynovitis, changes in tendon shape, and multiple subtendons can indicate a complete multifragmenting split tear. A defect on the surface of the tendon may indicate a partial-thickness split tear, commonly referred to as the "cleft sign." Peroneus subluxation is particularly likely when the superior peroneal retinaculum is torn. Given the subtlety of clinical symptoms, radiological evaluation is essential. Dynamic US assessment is especially valuable for detecting instability and split tears. This pictorial review presents the imaging spectrum of the most common pathologies of the peroneus brevis tendon on US and MRI.
腓肌腱病理在体力活动的个体中很常见,包括腱鞘炎、肌腱半脱位、撕裂和断裂。然而,诊断这些疾病,特别是腓骨短肌撕裂,在临床和影像学上都是具有挑战性的。磁共振成像(MRI)和超声(US)有时会遗漏裂开的眼泪。腓骨肌撕裂的很大一部分是在肌腱病变的背景下发生的。腱鞘炎、肌腱形状改变和多个次肌腱的出现可提示完全性多裂性撕裂。肌腱表面的缺陷可能表明部分厚度的撕裂,通常被称为“裂征”。腓骨半脱位特别可能发生在腓骨上支持带撕裂时。鉴于临床症状的微妙性,放射学评估是必不可少的。动态US评估对于检测不稳定和撕裂特别有价值。这篇图片综述介绍了在US和MRI上腓骨短肌腱最常见病理的成像谱。
{"title":"Peroneus brevis split tear – A challenging diagnosis: A pictorial review of magnetic resonance and ultrasound imaging – Part 2: Imaging with magnetic resonance and ultrasound","authors":"Katarzyna Bokwa-Dąbrowska ,&nbsp;Dan Mocanu ,&nbsp;Isaac Romanus ,&nbsp;Rafał Zych ,&nbsp;Michael Huuskonen ,&nbsp;Pawel Szaro","doi":"10.1016/j.ejro.2024.100627","DOIUrl":"10.1016/j.ejro.2024.100627","url":null,"abstract":"<div><div>Peroneal tendon pathology is common among physically active individuals, with tenosynovitis, tendon subluxation, split tears and rupture. However, diagnosing these conditions, particularly peroneus brevis split tears, is clinically and radiologically challenging. Magnetic resonance imaging (MRI) and ultrasound (US) can sometimes miss split tears. A significant portion of peroneus split tears develops on a background of tendinopathy. The presence of tenosynovitis, changes in tendon shape, and multiple subtendons can indicate a complete multifragmenting split tear. A defect on the surface of the tendon may indicate a partial-thickness split tear, commonly referred to as the \"cleft sign.\" Peroneus subluxation is particularly likely when the superior peroneal retinaculum is torn. Given the subtlety of clinical symptoms, radiological evaluation is essential. Dynamic US assessment is especially valuable for detecting instability and split tears. This pictorial review presents the imaging spectrum of the most common pathologies of the peroneus brevis tendon on US and MRI.</div></div>","PeriodicalId":38076,"journal":{"name":"European Journal of Radiology Open","volume":"14 ","pages":"Article 100627"},"PeriodicalIF":1.8,"publicationDate":"2024-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11733185/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rare pancreatic cystic neoplasms: A pictorial review 罕见胰腺囊性肿瘤:图片综述。
IF 1.8 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-12-21 DOI: 10.1016/j.ejro.2024.100620
Francescamaria Donati, Rosa Cervelli, Piero Boraschi
Since rare pancreatic cystic tumors may differ from common pancreatic cystic neoplasms in terms of treatment plan and prognosis, the differential diagnosis of these diseases is clinically relevant. Various imaging tests play an important role in the differential diagnosis of rare cystic pancreatic tumors, but accurately distinguishing these diseases solely on the basis of imaging findings is challenging. The purpose of this pictorial review is to present CT and in particular MR imaging features of rare pancreatic cystic tumors and discuss potential elements for differential diagnosis.
由于罕见胰腺囊性肿瘤与常见胰腺囊性肿瘤在治疗方案和预后方面存在差异,因此对其进行鉴别诊断具有临床意义。各种影像学检查在罕见的囊性胰腺肿瘤的鉴别诊断中发挥着重要作用,但仅根据影像学表现准确区分这些疾病是具有挑战性的。这篇图片综述的目的是介绍罕见胰腺囊性肿瘤的CT和MR成像特征,并讨论鉴别诊断的潜在因素。
{"title":"Rare pancreatic cystic neoplasms: A pictorial review","authors":"Francescamaria Donati,&nbsp;Rosa Cervelli,&nbsp;Piero Boraschi","doi":"10.1016/j.ejro.2024.100620","DOIUrl":"10.1016/j.ejro.2024.100620","url":null,"abstract":"<div><div>Since rare pancreatic cystic tumors may differ from common pancreatic cystic neoplasms in terms of treatment plan and prognosis, the differential diagnosis of these diseases is clinically relevant. Various imaging tests play an important role in the differential diagnosis of rare cystic pancreatic tumors, but accurately distinguishing these diseases solely on the basis of imaging findings is challenging. The purpose of this pictorial review is to present CT and in particular MR imaging features of rare pancreatic cystic tumors and discuss potential elements for differential diagnosis.</div></div>","PeriodicalId":38076,"journal":{"name":"European Journal of Radiology Open","volume":"14 ","pages":"Article 100620"},"PeriodicalIF":1.8,"publicationDate":"2024-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11730956/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142985029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differences in myocardial involvement between new onset and longstanding systemic lupus erythematosus patients assessed by cardiovascular magnetic resonance 心血管磁共振评估新发和长期系统性红斑狼疮患者心肌受累的差异。
IF 1.8 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-12-20 DOI: 10.1016/j.ejro.2024.100623
Zhen Wang , Xing Tang , Chaohui Hang , Hui Gao , Jinxiu Yang , Yuchi Han , Yongqiang Yu , Zongwen Shuai , Ren Zhao , Xiaohu Li

Objectives

Subclinical myocardial involvement is common in systemic lupus erythematosus (SLE), but differences between new onset and longstanding SLE are not fully elucidated. This study compared myocardial involvement in new onset versus longstanding SLE using cardiovascular magnetic resonance (CMR).

Materials and methods

We prospectively enrolled 24 drug-naïve new onset SLE patients, 27 longstanding SLE patients, and 20 healthy controls. All participants underwent clinical evaluation and CMR examination. We analyzed left ventricular (LV) morphological, functional parameters, and tissue characterization parameters: native T1, T2, extracellular volume fraction (ECV), and late gadolinium enhancement (LGE).

Results

Both new onset and longstanding SLE groups showed elevated native T1, T2, and ECV values compared to the control group (all P < 0.05). Additionally, the new onset SLE group exhibited higher T2 values compared to the longstanding SLE group [55.3 vs. 52.8 ms, P < 0.05]. The new onset group also demonstrated higher left ventricular (LV) end-diastolic volume index (LVEDVi), LV end-systolic volume index (LVSVi), and LV mass index (LVMi) than controls (all P < 0.05), with LVEDVi significantly higher than in the longstanding group (P < 0.05).

Conclusion

CMR tissue characterization imaging can detect early myocardial involvement in patients with new onset and longstanding SLE. Patients with new onset SLE exhibit more pronounced myocardial edema than those with longstanding SLE. This suggests that SLE patients are at risk of myocardial damage at various stages of the disease, underscoring the need for early monitoring and long-term management to prevent the progression of myocardial remodeling.
目的:亚临床心肌受累在系统性红斑狼疮(SLE)中很常见,但新发和长期SLE之间的差异尚未完全阐明。这项研究使用心血管磁共振(CMR)比较了新发和长期SLE的心肌受累情况。材料和方法:我们前瞻性地招募了24例drug-naïve新发SLE患者,27例长期SLE患者和20例健康对照。所有参与者均进行了临床评估和CMR检查。我们分析了左心室(LV)形态学、功能参数和组织表征参数:原生T1、T2、细胞外体积分数(ECV)和晚期钆增强(LGE)。结果:与对照组相比,新发和长期SLE组的T1、T2和ECV值均升高(P均为 )。结论:CMR组织表征成像可以检测新发和长期SLE患者的早期心肌受累。新发SLE患者比长期SLE患者表现出更明显的心肌水肿。这表明SLE患者在疾病的各个阶段都有心肌损伤的风险,强调早期监测和长期管理的必要性,以防止心肌重构的进展。
{"title":"Differences in myocardial involvement between new onset and longstanding systemic lupus erythematosus patients assessed by cardiovascular magnetic resonance","authors":"Zhen Wang ,&nbsp;Xing Tang ,&nbsp;Chaohui Hang ,&nbsp;Hui Gao ,&nbsp;Jinxiu Yang ,&nbsp;Yuchi Han ,&nbsp;Yongqiang Yu ,&nbsp;Zongwen Shuai ,&nbsp;Ren Zhao ,&nbsp;Xiaohu Li","doi":"10.1016/j.ejro.2024.100623","DOIUrl":"10.1016/j.ejro.2024.100623","url":null,"abstract":"<div><h3>Objectives</h3><div>Subclinical myocardial involvement is common in systemic lupus erythematosus (SLE), but differences between new onset and longstanding SLE are not fully elucidated. This study compared myocardial involvement in new onset versus longstanding SLE using cardiovascular magnetic resonance (CMR).</div></div><div><h3>Materials and methods</h3><div>We prospectively enrolled 24 drug-naïve new onset SLE patients, 27 longstanding SLE patients, and 20 healthy controls. All participants underwent clinical evaluation and CMR examination. We analyzed left ventricular (LV) morphological, functional parameters, and tissue characterization parameters: native T1, T2, extracellular volume fraction (ECV), and late gadolinium enhancement (LGE).</div></div><div><h3>Results</h3><div>Both new onset and longstanding SLE groups showed elevated native T1, T2, and ECV values compared to the control group (all P &lt; 0.05). Additionally, the new onset SLE group exhibited higher T2 values compared to the longstanding SLE group [55.3 vs. 52.8 ms, P &lt; 0.05]. The new onset group also demonstrated higher left ventricular (LV) end-diastolic volume index (LVEDVi), LV end-systolic volume index (LVSVi), and LV mass index (LVMi) than controls (all P &lt; 0.05), with LVEDVi significantly higher than in the longstanding group (P &lt; 0.05).</div></div><div><h3>Conclusion</h3><div>CMR tissue characterization imaging can detect early myocardial involvement in patients with new onset and longstanding SLE. Patients with new onset SLE exhibit more pronounced myocardial edema than those with longstanding SLE. This suggests that SLE patients are at risk of myocardial damage at various stages of the disease, underscoring the need for early monitoring and long-term management to prevent the progression of myocardial remodeling.</div></div>","PeriodicalId":38076,"journal":{"name":"European Journal of Radiology Open","volume":"14 ","pages":"Article 100623"},"PeriodicalIF":1.8,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11731982/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142985000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deep learning radiomics analysis for prediction of survival in patients with unresectable gastric cancer receiving immunotherapy 深度学习放射组学分析用于预测接受免疫治疗的不可切除胃癌患者的生存。
IF 1.8 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-12-19 DOI: 10.1016/j.ejro.2024.100626
Miaomiao Gou , Hongtao Zhang , Niansong Qian , Yong Zhang , Zeyu Sun , Guang Li , Zhikuan Wang , Guanghai Dai

Objective

Immunotherapy has become an option for the first-line therapy of advanced gastric cancer (GC), with improved survival. Our study aimed to investigate unresectable GC from an imaging perspective combined with clinicopathological variables to identify patients who were most likely to benefit from immunotherapy.

Method

Patients with unresectable GC who were consecutively treated with immunotherapy at two different medical centers of Chinese PLA General Hospital were included and divided into the training and validation cohorts, respectively. A deep learning neural network, using a multimodal ensemble approach based on CT imaging data before immunotherapy, was trained in the training cohort to predict survival, and an internal validation cohort was constructed to select the optimal ensemble model. Data from another cohort were used for external validation. The area under the receiver operating characteristic curve was analyzed to evaluate performance in predicting survival. Detailed clinicopathological data and peripheral blood prior to immunotherapy were collected for each patient. Univariate and multivariable logistic regression analysis of imaging models and clinicopathological variables was also applied to identify the independent predictors of survival. A nomogram based on multivariable logistic regression was constructed.

Result

A total of 79 GC patients in the training cohort and 97 patients in the external validation cohort were enrolled in this study. A multi-model ensemble approach was applied to train a model to predict the 1-year survival of GC patients. Compared to individual models, the ensemble model showed improvement in performance metrics in both the internal and external validation cohorts. There was a significant difference in overall survival (OS) among patients with different imaging models based on the optimum cutoff score of 0.5 (HR = 0.20, 95 % CI: 0.10–0.37, P < 0.001). Multivariate Cox regression analysis revealed that the imaging models, PD-L1 expression, and lung immune prognostic index were independent prognostic factors for OS. We combined these variables and built a nomogram. The calibration curves showed that the C-index of the nomogram was 0.85 and 0.78 in the training and validation cohorts.

Conclusion

The deep learning model in combination with several clinical factors showed predictive value for survival in patients with unresectable GC receiving immunotherapy.
目的:免疫治疗已成为晚期胃癌(GC)一线治疗的一种选择,可提高生存率。我们的研究旨在从影像学角度结合临床病理变量来研究不可切除的胃癌,以确定最有可能从免疫治疗中获益的患者。方法:选取在中国人民解放军总医院两个不同医疗中心连续接受免疫治疗的不可切除胃癌患者,分为训练组和验证组。采用基于免疫治疗前CT成像数据的多模态集成方法,在训练队列中训练深度学习神经网络以预测生存,并构建内部验证队列以选择最优集成模型。来自另一个队列的数据用于外部验证。分析受试者工作特征曲线下的面积,以评估预测生存的表现。我们收集了每位患者免疫治疗前的详细临床病理资料和外周血。影像学模型和临床病理变量的单因素和多因素logistic回归分析也被用于确定生存的独立预测因素。构造了基于多变量logistic回归的nomogram。结果:本研究共纳入79例训练组GC患者和97例外部验证组GC患者。采用多模型集成方法训练预测胃癌患者1年生存率的模型。与单个模型相比,集成模型在内部和外部验证队列中都显示出性能指标的改进。不同影像模型患者的总生存期(OS)差异有统计学意义,最佳截止评分为0.5 (HR = 0.20,95 % CI: 0.10-0.37, P )结论:深度学习模型结合多个临床因素对不可切除胃癌患者接受免疫治疗的生存具有预测价值。
{"title":"Deep learning radiomics analysis for prediction of survival in patients with unresectable gastric cancer receiving immunotherapy","authors":"Miaomiao Gou ,&nbsp;Hongtao Zhang ,&nbsp;Niansong Qian ,&nbsp;Yong Zhang ,&nbsp;Zeyu Sun ,&nbsp;Guang Li ,&nbsp;Zhikuan Wang ,&nbsp;Guanghai Dai","doi":"10.1016/j.ejro.2024.100626","DOIUrl":"10.1016/j.ejro.2024.100626","url":null,"abstract":"<div><h3>Objective</h3><div>Immunotherapy has become an option for the first-line therapy of advanced gastric cancer (GC), with improved survival. Our study aimed to investigate unresectable GC from an imaging perspective combined with clinicopathological variables to identify patients who were most likely to benefit from immunotherapy.</div></div><div><h3>Method</h3><div>Patients with unresectable GC who were consecutively treated with immunotherapy at two different medical centers of Chinese PLA General Hospital were included and divided into the training and validation cohorts, respectively. A deep learning neural network, using a multimodal ensemble approach based on CT imaging data before immunotherapy, was trained in the training cohort to predict survival, and an internal validation cohort was constructed to select the optimal ensemble model. Data from another cohort were used for external validation. The area under the receiver operating characteristic curve was analyzed to evaluate performance in predicting survival. Detailed clinicopathological data and peripheral blood prior to immunotherapy were collected for each patient. Univariate and multivariable logistic regression analysis of imaging models and clinicopathological variables was also applied to identify the independent predictors of survival. A nomogram based on multivariable logistic regression was constructed.</div></div><div><h3>Result</h3><div>A total of 79 GC patients in the training cohort and 97 patients in the external validation cohort were enrolled in this study. A multi-model ensemble approach was applied to train a model to predict the 1-year survival of GC patients. Compared to individual models, the ensemble model showed improvement in performance metrics in both the internal and external validation cohorts. There was a significant difference in overall survival (OS) among patients with different imaging models based on the optimum cutoff score of 0.5 (HR = 0.20, 95 % CI: 0.10–0.37, <em>P</em> &lt; 0.001). Multivariate Cox regression analysis revealed that the imaging models, PD-L1 expression, and lung immune prognostic index were independent prognostic factors for OS. We combined these variables and built a nomogram. The calibration curves showed that the C-index of the nomogram was 0.85 and 0.78 in the training and validation cohorts.</div></div><div><h3>Conclusion</h3><div>The deep learning model in combination with several clinical factors showed predictive value for survival in patients with unresectable GC receiving immunotherapy.</div></div>","PeriodicalId":38076,"journal":{"name":"European Journal of Radiology Open","volume":"14 ","pages":"Article 100626"},"PeriodicalIF":1.8,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11728962/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142979626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The predictive power of baseline metabolic and volumetric [18F]FDG PET parameters with different thresholds for early therapy failure and mortality risk in DLBCL patients undergoing CAR-T-cell therapy 不同阈值的基线代谢和体积[18F]FDG PET参数对接受car - t细胞治疗的DLBCL患者早期治疗失败和死亡风险的预测能力
IF 1.8 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-12-17 DOI: 10.1016/j.ejro.2024.100619
Emil Novruzov , Helena A. Peters , Kai Jannusch , Guido Kobbe , Sascha Dietrich , Johannes C. Fischer , Jutta Rox , Gerald Antoch , Frederik L. Giesel , Christina Antke , Ben-Niklas Baermann , Eduards Mamlins

Objective

[18F]FDG imaging is an integral part of patient management in CAR-T-cell therapy for recurrent or therapy-refractory DLBCL. The calculation methods of predictive power of specific imaging parameters still remains elusive. With this retrospective study, we sought to evaluate the predictive power of the baseline metabolic parameters and tumor burden calculated with automated segmentation via different thresholding methods for early therapy failure and mortality risk in DLBCL patients.

Materials and methods

Eighteen adult patients were enrolled, who underwent CAR-T-cell therapy accompanied by at least one pretherapeutic and two posttherapeutic [18F]FDG PET scans within 30 and 90 days between December 2018 and October 2023. We performed single-click automatic segmentation within VOIs in addition to extracting the SUV parameters to calculate the MTVs and TLGs by applying thresholds based on the concepts of a fixed absolute threshold with an SUVmax > 4.0, a relative absolute threshold with an isocontour of > 40 % of the SUVmax, a background threshold involving the addition of the liver SUV value and its 2 SD values, and only the liver SUV value.

Results

For early therapy failure, baseline metabolic parameters such as the SUVmax, SUVpeak and SUVmean tended to have greater predictive power than did the baseline metabolic burden. However, the baseline metabolic burden was superior in the prediction of mortality risk regardless of the thresholding method used.

Conclusion

This study revealed that automated delineation methods of metabolic tumor burden using different thresholds do not differ in outcome substantially. Therefore, the current clinical standard with a fixed absolute threshold value of SUV > 4.0 seems to be a feasible option.
目的:[18F]FDG成像是car - t细胞治疗复发性或难治性DLBCL患者管理的重要组成部分。具体成像参数预测能力的计算方法仍是一个谜。在这项回顾性研究中,我们试图评估基线代谢参数和通过不同阈值方法自动分割计算的肿瘤负荷对DLBCL患者早期治疗失败和死亡风险的预测能力。材料和方法:纳入18名成年患者,他们在2018年12月至2023年10月的30天和90天内接受了car - t细胞治疗,同时进行了至少一次治疗前和两次治疗后[18F]FDG PET扫描。基于SUVmax > 4.0的固定绝对阈值、等值线> 40 %的相对绝对阈值、肝脏SUV值及其2个 SD值的背景阈值和仅肝脏SUV值的概念,我们在提取SUV参数的基础上,对voi进行了一键式自动分割,计算出mtv和tlg。结果:对于早期治疗失败,基线代谢参数如SUVmax、SUVpeak和SUVmean往往比基线代谢负担具有更大的预测能力。然而,无论采用何种阈值法,基线代谢负担在预测死亡风险方面都更优越。结论:本研究表明,使用不同阈值的代谢性肿瘤负荷自动描述方法在结果上没有实质性差异。因此,目前的临床标准将SUV > 4.0作为固定的绝对阈值似乎是一个可行的选择。
{"title":"The predictive power of baseline metabolic and volumetric [18F]FDG PET parameters with different thresholds for early therapy failure and mortality risk in DLBCL patients undergoing CAR-T-cell therapy","authors":"Emil Novruzov ,&nbsp;Helena A. Peters ,&nbsp;Kai Jannusch ,&nbsp;Guido Kobbe ,&nbsp;Sascha Dietrich ,&nbsp;Johannes C. Fischer ,&nbsp;Jutta Rox ,&nbsp;Gerald Antoch ,&nbsp;Frederik L. Giesel ,&nbsp;Christina Antke ,&nbsp;Ben-Niklas Baermann ,&nbsp;Eduards Mamlins","doi":"10.1016/j.ejro.2024.100619","DOIUrl":"10.1016/j.ejro.2024.100619","url":null,"abstract":"<div><h3>Objective</h3><div>[<sup>18</sup>F]FDG imaging is an integral part of patient management in CAR-T-cell therapy for recurrent or therapy-refractory DLBCL. The calculation methods of predictive power of specific imaging parameters still remains elusive. With this retrospective study, we sought to evaluate the predictive power of the baseline metabolic parameters and tumor burden calculated with automated segmentation via different thresholding methods for early therapy failure and mortality risk in DLBCL patients.</div></div><div><h3>Materials and methods</h3><div>Eighteen adult patients were enrolled, who underwent CAR-T-cell therapy accompanied by at least one pretherapeutic and two posttherapeutic [<sup>18</sup>F]FDG PET scans within 30 and 90 days between December 2018 and October 2023. We performed single-click automatic segmentation within VOIs in addition to extracting the SUV parameters to calculate the MTVs and TLGs by applying thresholds based on the concepts of a fixed absolute threshold with an SUV<sub>max</sub> &gt; 4.0, a relative absolute threshold with an isocontour of &gt; 40 % of the SUV<sub>max</sub>, a background threshold involving the addition of the liver SUV value and its 2 SD values, and only the liver SUV value.</div></div><div><h3>Results</h3><div>For early therapy failure, baseline metabolic parameters such as the SUV<sub>max</sub>, SUV<sub>peak</sub> and SUV<sub>mean</sub> tended to have greater predictive power than did the baseline metabolic burden. However, the baseline metabolic burden was superior in the prediction of mortality risk regardless of the thresholding method used.</div></div><div><h3>Conclusion</h3><div>This study revealed that automated delineation methods of metabolic tumor burden using different thresholds do not differ in outcome substantially. Therefore, the current clinical standard with a fixed absolute threshold value of SUV &gt; 4.0 seems to be a feasible option.</div></div>","PeriodicalId":38076,"journal":{"name":"European Journal of Radiology Open","volume":"14 ","pages":"Article 100619"},"PeriodicalIF":1.8,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11719856/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preliminary study on detection and diagnosis of focal liver lesions based on a deep learning model using multimodal PET/CT images 基于多模态PET/CT图像深度学习模型的局灶性肝脏病变检测与诊断初探
IF 1.8 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-12-17 DOI: 10.1016/j.ejro.2024.100624
Yingqi Luo , Qingqi Yang , Jinglang Hu , Xiaowen Qin , Shengnan Jiang , Ying Liu

Objectives

To develop and validate a deep learning model using multimodal PET/CT imaging for detecting and classifying focal liver lesions (FLL).

Methods

This study included 185 patients who underwent 18F-FDG PET/CT imaging at our institution from March 2022 to February 2023. We analyzed serological data and imaging. Liver lesions were segmented on PET and CT, serving as the "reference standard". Deep learning models were trained using PET and CT images to generate predicted segmentations and classify lesion nature. Model performance was evaluated by comparing the predicted segmentations with the reference segmentations, using metrics such as Dice, Precision, Recall, F1-score, ROC, and AUC, and compared it with physician diagnoses.

Results

This study finally included 150 patients, comprising 46 patients with benign liver nodules, 51 patients with malignant liver nodules, and 53 patients with no FLLs. Significant differences were observed among groups for age, AST, ALP, GGT, AFP, CA19–9and CEA. On the validation set, the Dice coefficient of the model was 0.740. For the normal group, the recall was 0.918, precision was 0.904, F1-score was 0.909, and AUC was 0.976. For the benign group, the recall was 0.869, precision was 0.862, F1-score was 0.863, and AUC was 0.928. For the malignant group, the recall was 0.858, precision was 0.914, F1-score was 0.883, and AUC was 0.979. The model's overall diagnostic performance was between that of junior and senior physician.

Conclusion

This deep learning model demonstrated high sensitivity in detecting FLLs and effectively differentiated between benign and malignant lesions.
目的:开发并验证一种使用多模态PET/CT成像检测和分类局灶性肝脏病变(FLL)的深度学习模型。方法:本研究纳入了从2022年3月至2023年2月在我院接受18F-FDG PET/CT成像的185例患者。我们分析血清学资料和影像。在PET和CT上对肝脏病变进行分割,作为“参考标准”。使用PET和CT图像训练深度学习模型,生成预测分割并对病变性质进行分类。通过使用Dice、Precision、Recall、F1-score、ROC和AUC等指标将预测分割与参考分割进行比较,并将其与医生诊断进行比较,从而评估模型的性能。结果:本研究最终纳入150例患者,其中良性肝结节46例,恶性肝结节51例,无fll患者53例。年龄、AST、ALP、GGT、AFP、ca19 -9、CEA组间差异有统计学意义。在验证集上,模型的Dice系数为0.740。正常组的召回率为0.918,精密度为0.904,f1评分为0.909,AUC为0.976。良性组的召回率为0.869,精密度为0.862,f1评分为0.863,AUC为0.928。恶性组的召回率为0.858,准确率为0.914,f1评分为0.883,AUC为0.979。该模型的整体诊断性能介于初级和高级医师之间。结论:该深度学习模型对fll的检测灵敏度高,能有效区分良恶性病变。
{"title":"Preliminary study on detection and diagnosis of focal liver lesions based on a deep learning model using multimodal PET/CT images","authors":"Yingqi Luo ,&nbsp;Qingqi Yang ,&nbsp;Jinglang Hu ,&nbsp;Xiaowen Qin ,&nbsp;Shengnan Jiang ,&nbsp;Ying Liu","doi":"10.1016/j.ejro.2024.100624","DOIUrl":"10.1016/j.ejro.2024.100624","url":null,"abstract":"<div><h3>Objectives</h3><div>To develop and validate a deep learning model using multimodal PET/CT imaging for detecting and classifying focal liver lesions (FLL).</div></div><div><h3>Methods</h3><div>This study included 185 patients who underwent <sup>18</sup>F-FDG PET/CT imaging at our institution from March 2022 to February 2023. We analyzed serological data and imaging. Liver lesions were segmented on PET and CT, serving as the \"reference standard\". Deep learning models were trained using PET and CT images to generate predicted segmentations and classify lesion nature. Model performance was evaluated by comparing the predicted segmentations with the reference segmentations, using metrics such as Dice, Precision, Recall, F1-score, ROC, and AUC, and compared it with physician diagnoses.</div></div><div><h3>Results</h3><div>This study finally included 150 patients, comprising 46 patients with benign liver nodules, 51 patients with malignant liver nodules, and 53 patients with no FLLs. Significant differences were observed among groups for age, AST, ALP, GGT, AFP, CA19–9and CEA. On the validation set, the Dice coefficient of the model was 0.740. For the normal group, the recall was 0.918, precision was 0.904, F1-score was 0.909, and AUC was 0.976. For the benign group, the recall was 0.869, precision was 0.862, F1-score was 0.863, and AUC was 0.928. For the malignant group, the recall was 0.858, precision was 0.914, F1-score was 0.883, and AUC was 0.979. The model's overall diagnostic performance was between that of junior and senior physician.</div></div><div><h3>Conclusion</h3><div>This deep learning model demonstrated high sensitivity in detecting FLLs and effectively differentiated between benign and malignant lesions.</div></div>","PeriodicalId":38076,"journal":{"name":"European Journal of Radiology Open","volume":"14 ","pages":"Article 100624"},"PeriodicalIF":1.8,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11720101/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Journal of Radiology Open
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1